BRIEF-Lundbeck, Takeda receive CRL from FDA for Trintellix (vortioxetine) sNDA
June 22, 2017 at 20:39 PM EDT
* Lundbeck and Takeda receive complete response letter from the FDA for Trintellix® (vortioxetine) sNDA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.